A cluster randomised controlled trial of a MedicineInsight educational quality improvement program to improve the diagnosis and treatment of chronic hepatitis C in Australian general practice - the EQUIP-HEPC trial

PS MedicineWise (Not-for-profit)0 个研究点目标入组 201 人开始时间: 2019年3月28日最近更新: 2021年11月15日

试验速览

暂无简介。

•General Practice sites:
•1.Participates in the MedicineInsight Program and meets MedicineInsight data quality requirements
•2.Located in a geographical area serviced by one of the CSS field force delivering the intervention
•3.Use of Medical Director or Best Practice for EHR management
•4.Has 5 or more patients with possible or confirmed CHC* who visited the practice at least once in the 2 years prior to randomisation
•*As part of a previous project related to hepatitis C, we have developed a set of search algorithms that scan the data in MedicineInsight for terms that indicate confirmed or possible CHC. These algorithms and terms are outlined in detail by Chidwick et al (2018) . The algorithms search for a patient’s most recent docle and pyefinch codes as well as free text expressions pertaining to hepatitis C in clinical system records that describe reason for encounter, reason for prescription, or diagnosis. Additional criteria are applied to confirm CHC in patients whose most recent status is indeterminate, including prescriptions, tests, and complications related to CHC.

•Practices that participated in the 2017 NPS MedicineWise educational program on Hepatitis C will be excluded.
•Practices that withdraw their consent to participate in this study, or in the MedicineInsight program, during the period of analysis will not be included in this study. Practice-level withdrawals are rare in MedicineInsight. Data for patients who opt-out from the program will be excluded from the study.

发起方

PS MedicineWise (Not-for-profit)